Cargando…
Veterinary pharmacovigilance in sub-Sahara Africa context: a pilot study of adverse reactions to veterinary medicine in Cameroon
BACKGROUND: Sub-Saharan African market is highly affected by counterfeit veterinary drugs. Though these counterfeit and non-compliance of drugs can induce adverse effects during their utilization, there is no monitoring system of veterinary medicines. The present pilot study was carried out in Camer...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701137/ https://www.ncbi.nlm.nih.gov/pubmed/31426790 http://dx.doi.org/10.1186/s12917-019-2043-1 |
_version_ | 1783445006903672832 |
---|---|
author | Mouiche, Mohamed Moctar Mouliom Njingou, Badou Zaki Ndouoya Moffo, Frédéric Mpouam, Serge Eugene Feussom, Jean Marc Kameni Awah-Ndukum, Julius |
author_facet | Mouiche, Mohamed Moctar Mouliom Njingou, Badou Zaki Ndouoya Moffo, Frédéric Mpouam, Serge Eugene Feussom, Jean Marc Kameni Awah-Ndukum, Julius |
author_sort | Mouiche, Mohamed Moctar Mouliom |
collection | PubMed |
description | BACKGROUND: Sub-Saharan African market is highly affected by counterfeit veterinary drugs. Though these counterfeit and non-compliance of drugs can induce adverse effects during their utilization, there is no monitoring system of veterinary medicines. The present pilot study was carried out in Cameroon to identify and describe suspected cases of adverse reactions to veterinary drugs in animals and / or humans as well as inefficacy of veterinary drugs. The methodology involved a descriptive cross-sectional survey of 67 actors in the veterinary medicine sector in Cameroon. RESULTS: A total of 74/120 (62%) cases of suspected adverse effects and or lack of efficacy of veterinary drugs in animals and 46 (38%) cases of adverse reactions in humans were identified. Antiparasitics were the most incriminated therapeutic class in animals (61%) and human (56%). Adverse reactions were reported in dogs (44%) and poultry (24%) while drug inefficacy was most observed in poultry (47%). According to animal health professionals, levamisole (24%) and ivermectin (16%) were identified to be responsible for the adverse effects and that the highest level of inefficacy was most frequently reported for oxytetracycline (29%). The main adverse reactions were systemic (22%), gastrointestinal (20%) and neurological (13%) disorders. CONCLUSION: The results of this study showed that misuse and circulation of poor quality as well as lack of efficacy of veterinary drugs is very common in Cameroon. Adverse reactions were observed in animals and humans. Therefore, the establishment of a national veterinary pharmacovigilance system based on solid legal bases is essential for a continuous assessment of the risks-benefits effects of veterinary drugs marketed in Cameroon. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12917-019-2043-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6701137 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-67011372019-08-26 Veterinary pharmacovigilance in sub-Sahara Africa context: a pilot study of adverse reactions to veterinary medicine in Cameroon Mouiche, Mohamed Moctar Mouliom Njingou, Badou Zaki Ndouoya Moffo, Frédéric Mpouam, Serge Eugene Feussom, Jean Marc Kameni Awah-Ndukum, Julius BMC Vet Res Research Article BACKGROUND: Sub-Saharan African market is highly affected by counterfeit veterinary drugs. Though these counterfeit and non-compliance of drugs can induce adverse effects during their utilization, there is no monitoring system of veterinary medicines. The present pilot study was carried out in Cameroon to identify and describe suspected cases of adverse reactions to veterinary drugs in animals and / or humans as well as inefficacy of veterinary drugs. The methodology involved a descriptive cross-sectional survey of 67 actors in the veterinary medicine sector in Cameroon. RESULTS: A total of 74/120 (62%) cases of suspected adverse effects and or lack of efficacy of veterinary drugs in animals and 46 (38%) cases of adverse reactions in humans were identified. Antiparasitics were the most incriminated therapeutic class in animals (61%) and human (56%). Adverse reactions were reported in dogs (44%) and poultry (24%) while drug inefficacy was most observed in poultry (47%). According to animal health professionals, levamisole (24%) and ivermectin (16%) were identified to be responsible for the adverse effects and that the highest level of inefficacy was most frequently reported for oxytetracycline (29%). The main adverse reactions were systemic (22%), gastrointestinal (20%) and neurological (13%) disorders. CONCLUSION: The results of this study showed that misuse and circulation of poor quality as well as lack of efficacy of veterinary drugs is very common in Cameroon. Adverse reactions were observed in animals and humans. Therefore, the establishment of a national veterinary pharmacovigilance system based on solid legal bases is essential for a continuous assessment of the risks-benefits effects of veterinary drugs marketed in Cameroon. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12917-019-2043-1) contains supplementary material, which is available to authorized users. BioMed Central 2019-08-19 /pmc/articles/PMC6701137/ /pubmed/31426790 http://dx.doi.org/10.1186/s12917-019-2043-1 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Mouiche, Mohamed Moctar Mouliom Njingou, Badou Zaki Ndouoya Moffo, Frédéric Mpouam, Serge Eugene Feussom, Jean Marc Kameni Awah-Ndukum, Julius Veterinary pharmacovigilance in sub-Sahara Africa context: a pilot study of adverse reactions to veterinary medicine in Cameroon |
title | Veterinary pharmacovigilance in sub-Sahara Africa context: a pilot study of adverse reactions to veterinary medicine in Cameroon |
title_full | Veterinary pharmacovigilance in sub-Sahara Africa context: a pilot study of adverse reactions to veterinary medicine in Cameroon |
title_fullStr | Veterinary pharmacovigilance in sub-Sahara Africa context: a pilot study of adverse reactions to veterinary medicine in Cameroon |
title_full_unstemmed | Veterinary pharmacovigilance in sub-Sahara Africa context: a pilot study of adverse reactions to veterinary medicine in Cameroon |
title_short | Veterinary pharmacovigilance in sub-Sahara Africa context: a pilot study of adverse reactions to veterinary medicine in Cameroon |
title_sort | veterinary pharmacovigilance in sub-sahara africa context: a pilot study of adverse reactions to veterinary medicine in cameroon |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701137/ https://www.ncbi.nlm.nih.gov/pubmed/31426790 http://dx.doi.org/10.1186/s12917-019-2043-1 |
work_keys_str_mv | AT mouichemohamedmoctarmouliom veterinarypharmacovigilanceinsubsaharaafricacontextapilotstudyofadversereactionstoveterinarymedicineincameroon AT njingoubadouzakindouoya veterinarypharmacovigilanceinsubsaharaafricacontextapilotstudyofadversereactionstoveterinarymedicineincameroon AT moffofrederic veterinarypharmacovigilanceinsubsaharaafricacontextapilotstudyofadversereactionstoveterinarymedicineincameroon AT mpouamsergeeugene veterinarypharmacovigilanceinsubsaharaafricacontextapilotstudyofadversereactionstoveterinarymedicineincameroon AT feussomjeanmarckameni veterinarypharmacovigilanceinsubsaharaafricacontextapilotstudyofadversereactionstoveterinarymedicineincameroon AT awahndukumjulius veterinarypharmacovigilanceinsubsaharaafricacontextapilotstudyofadversereactionstoveterinarymedicineincameroon |